22-23181460-A-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000305877.13(BCR):āc.500A>Cā(p.Gln167Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000311 in 1,607,520 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000305877.13 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BCR | NM_004327.4 | c.500A>C | p.Gln167Pro | missense_variant | 1/23 | ENST00000305877.13 | NP_004318.3 | |
BCR | NM_021574.3 | c.500A>C | p.Gln167Pro | missense_variant | 1/22 | NP_067585.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BCR | ENST00000305877.13 | c.500A>C | p.Gln167Pro | missense_variant | 1/23 | 1 | NM_004327.4 | ENSP00000303507 | P1 | |
BCR | ENST00000359540.7 | c.500A>C | p.Gln167Pro | missense_variant | 1/22 | 1 | ENSP00000352535 | |||
BCR | ENST00000479188.5 | n.129+1628A>C | intron_variant, non_coding_transcript_variant | 4 |
Frequencies
GnomAD3 genomes AF: 0.000197 AC: 30AN: 152162Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000165 AC: 4AN: 241738Hom.: 0 AF XY: 0.0000226 AC XY: 3AN XY: 132632
GnomAD4 exome AF: 0.0000137 AC: 20AN: 1455240Hom.: 0 Cov.: 33 AF XY: 0.0000152 AC XY: 11AN XY: 722964
GnomAD4 genome AF: 0.000197 AC: 30AN: 152280Hom.: 0 Cov.: 33 AF XY: 0.000242 AC XY: 18AN XY: 74462
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 05, 2024 | The c.500A>C (p.Q167P) alteration is located in exon 1 (coding exon 1) of the BCR gene. This alteration results from a A to C substitution at nucleotide position 500, causing the glutamine (Q) at amino acid position 167 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at